Marcus & Millichap (NYSE:MMI – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Friday, November 8th. Individual that are interested in registering for the company’s earnings conference call can do so using this link.
Marcus & Millichap (NYSE:MMI – Get Free Report) last announced its quarterly earnings data on Wednesday, August 7th. The real estate investment trust reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01. The business had revenue of $158.37 million during the quarter. Marcus & Millichap had a negative net margin of 5.68% and a negative return on equity of 5.50%.
Marcus & Millichap Stock Performance
Shares of MMI opened at $37.90 on Friday. The company has a 50-day simple moving average of $38.42 and a 200-day simple moving average of $35.53. The firm has a market capitalization of $1.47 billion, a P/E ratio of -41.65 and a beta of 1.13. Marcus & Millichap has a 52 week low of $28.42 and a 52 week high of $44.24.
Insider Activity at Marcus & Millichap
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on the stock. StockNews.com raised shares of Marcus & Millichap from a “sell” rating to a “hold” rating in a research report on Wednesday, July 24th. Wells Fargo & Company upped their target price on shares of Marcus & Millichap from $20.00 to $30.00 and gave the company an “underweight” rating in a research note on Friday, September 6th.
Read Our Latest Report on Marcus & Millichap
Marcus & Millichap Company Profile
Marcus & Millichap, Inc, an investment brokerage company, provides real estate investment brokerage and financing services to sellers and buyers of commercial real estate in the United States and Canada. The company offers commercial real estate investment sales, financing, research, and advisory services for multifamily, retail, office, industrial, single-tenant net lease, seniors housing, self-storage, hospitality, medical office, and manufactured housing, as well as capital markets.
See Also
- Five stocks we like better than Marcus & Millichap
- Which Wall Street Analysts are the Most Accurate?
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Short Selling: How to Short a Stock
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Health Care Stocks Explained: Why You Might Want to Invest
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Marcus & Millichap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marcus & Millichap and related companies with MarketBeat.com's FREE daily email newsletter.